← All stories
Health, Longevity & Biohacking

Mukherjee says early-onset colorectal cancer rise remains a mystery

By Egleze Editorial Desk · Published October 19, 2026 · Peter Attia Drive · 412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
Mukherjee says early-onset colorectal cancer rise remains a mystery
Peter Attia Drive
Peter Attia Drive
412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more

What was said

"In In the case of endometrial cancer in women, it's most likely because of increasing rates of obesity. Um and um but the rest of it is a is a mystery and the colorectal cancer business is a complete mystery."

Siddhartha Mukherjee says researchers still lack a clear explanation for rising colorectal cancer rates among younger people. He argues endometrial cancer is more likely increasing because of higher obesity rates.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Speaker
Siddhartha Mukherjee · guest
Programme
Peter Attia Drive
Episode
412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
Clip time
5:40
Original source
Watch the source segment →
From this episode
Peter Attia Drive
Peter Attia Drive

412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more

2h 4m · 7 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingMukherjee says US cancer mortality is falling, but younger colorectal cases rise→Health, Longevity & BiohackingMukherjee says CD19 CAR-T also wipes out healthy B cells→Health, Longevity & BiohackingMukherjee describes correlational CT-scan analysis where thymus presence tracked with fewer diseases including cancer→Health, Longevity & BiohackingMukherjee says GLP-1 add-on cancer trials should be randomised→
More stories More from Peter Attia Drive